Contineum Therapeutics, Inc. (CTNM)
11.95
+0.45
(+3.91%)
USD |
NASDAQ |
Sep 30, 09:30
Contineum Therapeutics Price to Book Value : 1.876 for Sept. 30, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 29, 2026 | 1.805 |
| September 28, 2026 | 1.998 |
| September 25, 2026 | 1.971 |
| September 24, 2026 | 1.960 |
| September 23, 2026 | 1.963 |
| September 22, 2026 | 2.103 |
| September 21, 2026 | 2.127 |
| September 18, 2026 | 2.124 |
| September 17, 2026 | 2.073 |
| September 16, 2026 | 2.160 |
| September 15, 2026 | 2.169 |
| September 14, 2026 | 2.326 |
| September 11, 2026 | 2.326 |
| September 10, 2026 | 2.301 |
| September 09, 2026 | 2.376 |
| September 08, 2026 | 2.502 |
| September 04, 2026 | 2.621 |
| September 03, 2026 | 2.758 |
| September 02, 2026 | 2.706 |
| September 01, 2026 | 2.597 |
| August 31, 2026 | 2.549 |
| August 28, 2026 | 2.676 |
| August 27, 2026 | 2.707 |
| August 26, 2026 | 2.671 |
| August 25, 2026 | 2.676 |
| Date | Value |
|---|---|
| August 24, 2026 | 2.61 |
| August 21, 2026 | 2.698 |
| August 20, 2026 | 2.514 |
| August 19, 2026 | 2.514 |
| August 18, 2026 | 2.276 |
| August 17, 2026 | 2.280 |
| August 14, 2026 | 2.227 |
| August 13, 2026 | 2.401 |
| August 12, 2026 | 2.351 |
| August 11, 2026 | 2.326 |
| August 10, 2026 | 2.274 |
| August 07, 2026 | 2.360 |
| August 06, 2026 | 2.409 |
| August 05, 2026 | 2.396 |
| August 04, 2026 | 2.495 |
| August 03, 2026 | 2.500 |
| July 31, 2026 | 2.431 |
| July 30, 2026 | 2.472 |
| July 29, 2026 | 2.257 |
| July 28, 2026 | 2.222 |
| July 27, 2026 | 2.175 |
| July 24, 2026 | 2.207 |
| July 23, 2026 | 2.255 |
| July 22, 2026 | 2.312 |
| July 21, 2026 | 2.182 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cocrystal Pharma, Inc. | 14.79 |
| CNBX Pharmaceuticals, Inc. | -- |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 0.8711 |
| Fulcrum Therapeutics, Inc. | 0.9159 |
Price to Book Value Related Metrics
| Price | 11.95 |
| Earnings Yield | -14.54% |
| Market Cap | 449.48M |